Sitagliptin selectively inhibits the action of DPP-4, the primary enzyme degrading the incretin hormones, allowing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback